1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)

Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)

  • April 2013
  • -
  • La Merie Publishing
  • -
  • 94 pages

Product description

The Competitive Intelligence Report Erythropoiesis Stimulating Agents (ESA) as of April 2013 provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of erythropoietin (EPO) in regulated markets, a compilation of novel, next generation Erythropoiesis Stimulating Agents (ESAs) separately for biologics and for oral small molecules and a summary of first generation EPO products as well as of darbepoietin biosimilar versions in less regulated markets.

Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed Erythropoieitin (EPO) & Erythropoiesis Stimulating Agents (ESA) products and active EPO and ESA projects in research and development. In addition, the report lists company-specific product portfolios and R&D pipelines of Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) on the market or in R&D. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)
Table of Contents

• First generation epoetins in regulated markets
• Second generation epoetins in regulated markets
• Epoetin biosimilars in regulated markets
• Darbepoetin biosimilars in regulated markets
• Next generation biologic Eythropoiesis Stimulating Agents (ESA) in regulated markets
• Next generation small molecule Erythropoiesis Stimulating Agents
• First generation EPO in less regulated markets (Central and South America; Africa; Asia; Rest of the World)
• Darbepoietin biosimilars in less regulated markets
• Next generation biologic Erythropoiesis Stimulating Agents (ESA) in less regulated markets
• About La Merie

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Erythropoietin (CAS 11096-26-7) Industry, 2016 Market Research Report

Global and Chinese Erythropoietin (CAS 11096-26-7) Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • October 2016
  • by Prof Research

The 'Global and Chinese Erythropoietin Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Erythropoietin industry with a focus on the Chinese ...

European Erythropoietin Market Outlook 2022

European Erythropoietin Market Outlook 2022

  • $ 1500
  • Industry report
  • October 2016
  • by RNCOS

Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its ...

Global Erythropoietin (EPO) Market with Focus on Asia- Industry Analysis & Outlook (2016-2020)

Global Erythropoietin (EPO) Market with Focus on Asia- Industry Analysis & Outlook (2016-2020)

  • $ 900
  • Industry report
  • November 2016
  • by Koncept Analytics

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.